These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10734643)
1. [General rules for the study of pancreatic cancer by molecular biological aspect]. Omata M; Tada M Nihon Geka Gakkai Zasshi; 2000 Feb; 101(2):233-6. PubMed ID: 10734643 [TBL] [Abstract][Full Text] [Related]
2. [Genetics of pancreatic cancer: recent advances in molecular diagnosis]. Hayashi N; Egami H; Ogawa M Nihon Geka Gakkai Zasshi; 2002 Jun; 103(6):476-81. PubMed ID: 12094699 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385 [TBL] [Abstract][Full Text] [Related]
5. SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001. Liu F Clin Cancer Res; 2001 Dec; 7(12):3853-6. PubMed ID: 11751474 [No Abstract] [Full Text] [Related]
6. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194 [TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive pathways in pancreatic carcinoma. Rozenblum E; Schutte M; Goggins M; Hahn SA; Panzer S; Zahurak M; Goodman SN; Sohn TA; Hruban RH; Yeo CJ; Kern SE Cancer Res; 1997 May; 57(9):1731-4. PubMed ID: 9135016 [TBL] [Abstract][Full Text] [Related]
8. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis. van Heek T; Rader AE; Offerhaus GJ; McCarthy DM; Goggins M; Hruban RH; Wilentz RE Am J Clin Pathol; 2002 May; 117(5):755-65. PubMed ID: 12090425 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours. Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258 [TBL] [Abstract][Full Text] [Related]
10. Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer. Salek C; Minarikova P; Benesova L; Nosek V; Strnad R; Zavoral M; Minarik M Anticancer Res; 2009 May; 29(5):1803-10. PubMed ID: 19443408 [TBL] [Abstract][Full Text] [Related]
13. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity. Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden). de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146 [TBL] [Abstract][Full Text] [Related]
15. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer]. Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060 [TBL] [Abstract][Full Text] [Related]
16. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Moore PS; Sipos B; Orlandini S; Sorio C; Real FX; Lemoine NR; Gress T; Bassi C; Klöppel G; Kalthoff H; Ungefroren H; Löhr M; Scarpa A Virchows Arch; 2001 Dec; 439(6):798-802. PubMed ID: 11787853 [TBL] [Abstract][Full Text] [Related]
17. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Moskaluk CA; Hruban RH; Kern SE Cancer Res; 1997 Jun; 57(11):2140-3. PubMed ID: 9187111 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405 [TBL] [Abstract][Full Text] [Related]
19. Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases. Costentin L; Pagès P; Bouisson M; Berthelémy P; Buscail L; Escourrou J; Pradayrol L; Vaysse N Pancreatology; 2002; 2(1):17-25. PubMed ID: 12120000 [TBL] [Abstract][Full Text] [Related]
20. p53 and DPC4 alterations in the bile of patients with pancreatic carcinoma. Pantalone D; Pelo E; Minuti B; Giotti I; Mazza E; Falchini M; Neri B; Nesi G; Roberta Girardi L; Pulli R; Credi G; Torricelli F J Surg Oncol; 2004 Dec; 88(4):210-6. PubMed ID: 15565642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]